How long does semaglutide stay in your system after you stop taking it?

What does a one-week half-life actually mean for clearance?

Half-life is the time a medicine takes for its concentration in your blood to fall by half. For semaglutide, that figure sits at roughly seven days. After one half-life, half the drug remains; after two, a quarter; after five, around three percent. In practical terms, most pharmacologists consider a medicine effectively cleared after four to five half-lives, which puts the clearance window at four to five weeks after your final injection.

You can get a rough sense of this yourself: count back five weeks from your last pen. If a noticeable appetite shift started to return before that point, it is likely because concentrations had already dropped enough to reduce the drug's effect on your hypothalamic hunger signals, even before full clearance. That kind of timeline tracking takes under a minute and gives you something concrete to discuss with your prescriber.

The NHS patient information on semaglutide confirms the once-weekly schedule is possible precisely because of this long half-life, the medicine maintains its effect between injections without a daily dose. Stopping breaks that steady state, and if you are wondering how long semaglutide will stay in your system after that point, blood levels decline in the same stepwise fashion, week by week.

Does the dose you were on change how long Wegovy stays in your system?

Not in terms of half-life. Whether you finished on 0.25 mg or 2.4 mg, the seven-day half-life is the same, the body clears semaglutide at the same rate regardless of concentration. What does differ is the starting point for clearance: a higher maintenance dose means a higher peak level, so although the proportional halving is identical, slightly more time may pass before the absolute amount drops to trace levels.

For most people the practical window remains four to five weeks. If you were on the newer higher-dose regimen, the answer to how long Wegovy stays in your system is effectively the same, five weeks covers it.

What matters more than the exact clearance date is what happens to appetite, blood glucose and body weight as levels fall. Those changes typically begin within two to three weeks of stopping, well before the medicine has fully cleared, because appetite suppression is sensitive to even modest drops in drug concentration. Our clinical team fields this question regularly, and the consistent advice is to have a plan in place before stopping rather than after.

What happens to weight and appetite in the weeks after stopping?

This is the part many people find hardest to hear, so it is worth being direct about it. Clinical evidence reviewed by NICE shows that weight regain typically begins within weeks of stopping a GLP-1 medicine, and over the following months a significant proportion of lost weight may return. The NICE technology appraisal for semaglutide (TA875) notes this pattern and is part of why the guidance frames treatment within a longer-term weight management strategy.

The physiological reason is straightforward. Semaglutide works by mimicking GLP-1, a hormone that signals fullness and slows gastric emptying. Once it clears, those signals return to their pre-treatment baseline. For most people that baseline involved a stronger drive to eat than they experienced on treatment, which is why hunger often rebounds noticeably. Our detailed guide on how long semaglutide lasts in your system explains why this rebound follows the same stepwise clearance curve.

This does not mean stopping is wrong for everyone. Sometimes a planned pause is appropriate, before surgery, during pregnancy planning, or while reassessing treatment goals. What it does mean is that stopping without a plan tends to undo results quickly. You can read more about the typical weight trajectory in our guide to how long after stopping semaglutide weight gain tends to start.

How does this clearance timeline affect practical decisions?

Knowing the five-week window is useful in several real situations. Contraception is one: MHRA guidance advises effective contraception both during semaglutide treatment and for a wash-out period before trying to conceive, so understanding when the medicine has actually cleared matters. Switching treatments is another: if your prescriber is considering moving you to a different medicine, the clearance timeline influences how and when that transition happens safely.

It also affects what results look like on a scale. Some people stop Wegovy and check their weight at the end of week five expecting to see the full maintained loss, but by then appetite has already rebounded for three weeks. The results pattern during active Wegovy treatment is very different from the post-stopping trajectory, and understanding that distinction prevents a lot of unnecessary confusion.

If you are thinking about starting, pausing or coming off treatment, the most useful step is a conversation with a prescriber who knows your history. You can explore what treatment looks like through a weight-loss treatment overview, or if you are ready to speak with our team, a free consultation is the right place to start.